The mechanism of action of BCG therapy for bladder cancer—a current perspective

By Gil Redelman-Sidi, M. Glickman, B. Bochner. Nature reviews. Urology, 2014

682 citations recorded by the source corpus.

Subfields: Immunology, Surgery

View Paper: https://www.semanticscholar.org/paper/5d36f01ae3441689cef50d0a5f86b801fa0b2fe5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. B. Goodman
2. H. Gardner

In Surgery

1. B. Goodman
2. H. Gardner

Citations in the corpus

• The microbiome and cancer (2018, background): “It seems to use a variety of immune-stimulating mechanisms to induce the antitumour response [78].”
• Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence (2020, neutral): “Bacillus Calmette–Guerin (BCG) vaccine, with its ability to induce inflammation, is still being effectively used for the treatment and secondary prevention of non-muscle invasive bladder cancer [8].”